| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/05/2014 | CN103550166A Rivaroxaban oral microsphere preparation |
| 02/05/2014 | CN103550163A Excipient of soluble powder for livestock and preparation method of excipient |
| 02/05/2014 | CN103550162A Preparation method of targeted ferroferric oxide-porphyrin containing composite nanoparticles |
| 02/05/2014 | CN103550161A Resveratrol loaded polyurethane micro-nano particle and preparation method thereof |
| 02/05/2014 | CN103550158A Emodin solid dispersion, drug-containing pellet core, colonic targeted micropill, and applications of three |
| 02/05/2014 | CN103550156A Preparation method of supermolecule globular micelle based on antidepressant medicament chlorpromazine |
| 02/05/2014 | CN103550155A Method of restraining production of lysophosphatide in lecithin/non-ionic surfactant mixed micelles |
| 02/05/2014 | CN103550154A Ziprasidone hydrochloride self-microemulsion preparation unaffected by food in absorption, and preparation method thereof |
| 02/05/2014 | CN103550153A Asarin pharmaceutical composition and preparation method of injection of asarin pharmaceutical composition |
| 02/05/2014 | CN103550152A Method for preparing veterinary long-acting injection containing tilmicosin |
| 02/05/2014 | CN103550151A Method for preparing long-acting injection containing cefquinome sulfate |
| 02/05/2014 | CN103550150A Improved dimethicone-containing injection |
| 02/05/2014 | CN103550149A Technology for preparing long-acting injection containing antiparasitic drugs |
| 02/05/2014 | CN103550148A Method for preparing long-acting injection containing tiamulin fumarate |
| 02/05/2014 | CN103550145A Chloramphenicol eye drops and preparation method thereof |
| 02/05/2014 | CN103550144A Levofloxacin hydrochloride composition injection and preparation method thereof |
| 02/05/2014 | CN103550143A Preparation method of levetiracetam injection |
| 02/05/2014 | CN103550142A Medicinal solution preparation prepared from acetylcysteine clathrate and preparation method thereof |
| 02/05/2014 | CN103550141A Pharmaceutical compositions containing a fluoroquinolone antibiotic drug |
| 02/05/2014 | CN103550140A Free alkali tolterodine filming hydrogel preparation and preparation method thereof through later drug loading |
| 02/05/2014 | CN103550139A Preparation method of injectable self-curing hypoglycemic hydrogel |
| 02/05/2014 | CN103550138A Sorafenib organogel and preparation method thereof |
| 02/05/2014 | CN103550137A Controlled release formulations of octreotide |
| 02/05/2014 | CN103549651A Toxicity attenuation cigarette with anti-cough effect |
| 02/05/2014 | CN103549650A Toxicity attenuation cigarette with pain easing and nerve soothing effects |
| 02/05/2014 | CN103549422A Konjac controlled-release colloidal particle |
| 02/05/2014 | CN103549113A Preparation method and application of modified vegetable protein |
| 02/05/2014 | CN103041383B Heatproof freeze-drying protective agent of live vaccine, live vaccine freeze-drying powder and preparation method thereof |
| 02/05/2014 | CN102836288B Magnetic Chinese medicine dressing for treating scars and preparation method of same |
| 02/05/2014 | CN102793679B Roxatidine acetate hydrochloride freeze-dried powder injection as well as preparation method and applications thereof |
| 02/05/2014 | CN102764433B Prawn white spot syndrome virus multivalent vector vaccine and application thereof |
| 02/05/2014 | CN102764426B Scorpion venom protein polypeptide colon-targeted preparation and preparation method thereof |
| 02/05/2014 | CN102716102B Mecobalamin tablet and preparation method thereof |
| 02/05/2014 | CN102603962B Preparation method of surface functionalized porous irregularly-shaped microspheres |
| 02/05/2014 | CN102526089B Pharmaceutical composition containing 13 vitamins |
| 02/05/2014 | CN102399808B Biodegradable non-viral gene carrier as well as preparation method thereof and application thereof |
| 02/05/2014 | CN102302507B Medicinal composition for directional controlled release of trace elements and preparation method and application |
| 02/05/2014 | CN102247329B 5,6,7,4'-tetrahydroxyflavone powder injection and preparation method thereof |
| 02/05/2014 | CN101874825B Medicinal composition for treating ulcerative colitis and preparation method thereof |
| 02/05/2014 | CN101874802B Slow-release medicinal composition for treating hypertension and high cholesterol |
| 02/04/2014 | US8642743 Method for reducing the immune response to a biologically active protein |
| 02/04/2014 | US8642666 Biodegradable block copolymeric compositions for drug delivery |
| 02/04/2014 | US8642662 Methods of using derivatives of (−)-venlafaxine |
| 02/04/2014 | US8642627 Formulation and use thereof |
| 02/04/2014 | US8642575 Method of inhibiting formation of volatile aldehydes and/or decomposition of fatty acids and use thereof |
| 02/04/2014 | US8642561 Peptides whose uptake by cells is controllable |
| 02/04/2014 | US8642531 Influenza antigen delivery vectors and constructs |
| 02/04/2014 | US8642089 Melt extrusion of salts of active ingredients |
| 02/04/2014 | US8642088 Tannin-chitosan composites |
| 02/04/2014 | US8642082 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 02/04/2014 | US8642056 Method for thickening a cosmetic formulation using an alkali swellable emulsion of a polymer with AMPS and which is rich in acrylic acid |
| 02/04/2014 | US8642053 Potentiated topical composition |
| 02/04/2014 | US8642051 Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s) |
| 02/04/2014 | US8642044 Prevention and treatment of amyloidogenic disease |
| 02/04/2014 | CA2770489C Bisphosphonate conjugates and methods of making and using the same |
| 02/04/2014 | CA2737769C Linear polyesteramides from aminophenolic esters |
| 02/04/2014 | CA2727642C Synthesis of cyclosporin analogs |
| 02/04/2014 | CA2702297C Novel crystalline forms of the anti-cancer compound zd1839 |
| 02/04/2014 | CA2697520C Use of lyophilised reduced diaminophenothiazines in the treatment of tau mediated neurological disorders |
| 02/04/2014 | CA2687178C Polymeric carriers for immunohistochemistry and in situ hybridization |
| 02/04/2014 | CA2671979C Pharmaceutical composition containing low-substituted hydroxypropyl cellulose |
| 02/04/2014 | CA2651102C Method of producing polysaccharide derivatives |
| 02/04/2014 | CA2645070C Pharmaceutical composition for external use |
| 02/04/2014 | CA2543530C Use of biocompatible polymers for the preparation of a composition or a medical device |
| 02/04/2014 | CA2539273C A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 02/04/2014 | CA2459891C Method and apparatus for nitric oxide generation |
| 02/04/2014 | CA2442533C A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 02/04/2014 | CA2432797C Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 01/30/2014 | WO2014018931A1 Methods and compositions for treating autoimmune disease |
| 01/30/2014 | WO2014018279A1 Film composition for hard capsule shells |
| 01/30/2014 | WO2014017999A1 Method for producing an agent for the treatment of tuberculosis |
| 01/30/2014 | WO2014017847A1 A liquid formulation of long-acting insulin conjugate |
| 01/30/2014 | WO2014017845A2 A liquid formulation of long acting insulinotropic peptide conjugate |
| 01/30/2014 | WO2014017756A1 Aqueous composition for preparing hard capsule, preparation method therefor, hard capsule, and method for recycling hard capsule scraps |
| 01/30/2014 | WO2014017595A1 Patch |
| 01/30/2014 | WO2014017594A1 Adhesive patch |
| 01/30/2014 | WO2014017593A1 Adhesive patch and production method therefor |
| 01/30/2014 | WO2014017573A1 Composition for agent for external use |
| 01/30/2014 | WO2014017507A1 Solid pharmaceutical preparation |
| 01/30/2014 | WO2014017411A1 External preparation for treating trichophytosis unguium |
| 01/30/2014 | WO2014016917A1 Acidic liquid nutrient |
| 01/30/2014 | WO2014016848A2 Solid forms of tyrosine kinase inhibitors, process for the preparation and their pharmaceutical composition thereof |
| 01/30/2014 | WO2014016504A1 System for delivering lectin-based active ingredients |
| 01/30/2014 | WO2014016460A1 Homo- and hetero-functionalised carbosilane dendritic compounds |
| 01/30/2014 | WO2014016428A1 Opioid formulations |
| 01/30/2014 | WO2014016380A1 Chondroitin complexes for transcutaneous absorption |
| 01/30/2014 | WO2014015444A1 Use of isotonic physiological electrolysis water for intravenous injection for combatting systemic viroses and bacterioses by means of oxidative radicals |
| 01/30/2014 | WO2014015443A1 Use of electrolysis water produced with the aid of diamond electrodes for the hydration, firming and care of skin, for the treatment of dermatoses, sunburn and general wounds |
| 01/30/2014 | WO2014015422A1 Cellulose-based nanoparticles for drug delivery |
| 01/30/2014 | WO2014015367A1 Polymers for sirna delivery |
| 01/30/2014 | WO2013183062A3 Palatable formulations of ibuprofen |
| 01/30/2014 | WO2013164121A4 Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas) |
| 01/30/2014 | WO2013144341A9 Microsphere compositions, preparation method and applications thereof |
| 01/30/2014 | WO2012160223A9 Pharmaceutical composition |
| 01/30/2014 | US20140031535 Beta-glucuronide-linker drug conjugates |
| 01/30/2014 | US20140031435 Propofol compositions and methods for reducing pain associated with propofol injection |
| 01/30/2014 | US20140031397 Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient |
| 01/30/2014 | US20140031396 Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient |
| 01/30/2014 | US20140031390 Pitavastatin-containing preparation and method for producing same |
| 01/30/2014 | US20140031314 Method of preparation of chitin and active principle complexes and complexes obtained |